Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 197.01B | 187.46B | 191.08B | 191.25B | 174.17B | 153.73B |
Gross Profit | 49.08B | 46.54B | 42.35B | 40.21B | 41.87B | 38.25B |
EBITDA | 19.84B | 18.59B | 14.94B | 14.49B | 16.36B | 12.95B |
Net Income | 13.17B | 12.20B | 9.60B | 9.28B | 10.01B | 7.53B |
Balance Sheet | ||||||
Total Assets | 125.50B | 120.73B | 102.19B | 95.22B | 87.36B | 77.25B |
Cash, Cash Equivalents and Short-Term Investments | 46.40B | 48.52B | 41.14B | 24.57B | 31.81B | 23.96B |
Total Debt | 11.88B | 14.97B | 10.09B | 12.71B | 9.29B | 10.93B |
Total Liabilities | 40.47B | 41.38B | 33.90B | 35.94B | 35.03B | 33.05B |
Stockholders Equity | 84.85B | 79.18B | 67.22B | 58.37B | 51.52B | 43.32B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 5.04B | 21.33B | -7.99B | 11.29B | 8.77B |
Operating Cash Flow | 0.00 | 8.20B | 24.02B | -6.76B | 13.17B | 10.58B |
Investing Cash Flow | 0.00 | -6.20B | -2.74B | -1.19B | -1.52B | -2.02B |
Financing Cash Flow | 0.00 | -132.00M | -5.81B | 224.00M | -4.07B | -5.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥163.64B | 15.06 | 10.97% | 2.67% | 7.11% | -0.27% | |
76 Outperform | $89.54B | 18.18 | 15.32% | 3.27% | -2.62% | 24.89% | |
76 Outperform | ¥124.18B | 8.85 | 3.40% | 10.52% | 15.36% | ||
75 Outperform | ¥101.91B | 14.00 | 2.81% | 8.95% | 4.60% | ||
73 Outperform | €162.84B | 5.23 | 30.22% | 1.69% | 5.27% | ― | |
71 Outperform | ¥91.49B | 21.33 | 4.88% | 0.03% | -23.96% | ||
69 Neutral | ¥228.59B | 14.33 | 7.64% | 2.71% | 9.13% | 8.49% |